API CAS 32986-56-4 Tobramycin Powder Raw Material Powder Tobramycin Antibiotics Tobramycin

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: D-sung Tobramycin
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Adult
• State: Powder
• Purity: >99%
• Product Name: Tobramycin
• Name: Tobramycin Powder
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 32986-56-4
• Mf: C18h37n5o9
• MW: 467.51400
• Melting Point: 178 C
• Boiling Point: 775.4ºC at 760 Mmhg
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 1000kg/Month

Product Description

API CAS 32986-56-4 Tobramycin Powder Raw Material Powder Tobramycin Antibiotics Tobramycin
 

Product Description

Product Details

 

Product Name	Tobramycin
Appearance	White Powder
CAS No.	32986-56-4
MF	C18H37N5O9

Tobramycin, also known as topramycin, is an organic compound with the chemical formula C18H37N5O9. It is an aminoglycoside antibiotic. Clinically, it is mainly suitable for treating neonatal sepsis, sepsis, central nervous system infections (including meningitis), urinary and reproductive system infections, lung infections, and other diseases caused by Gram negative bacteria.

Application&Function

This product is applicable to neonatal sepsis, sepsis, central nervous system infection (including meningitis), urogenital system infection, lung infection, biliary tract infection, abdominal cavity infection (and peritonitis), bone infection, skin infection Soft tissue infections (including burns), acute and chronic otitis media, sinusitis, etc. This product can be administered by intrathecal injection simultaneously when used for Pseudomonas aeruginosa meningitis or ventricular inflammation; When used for bronchial and pulmonary infections, the product can be inhaled simultaneously as an auxiliary treatment. Tobramycin is ineffective against most group D streptococcal infections. It is effective for bacterial infections in the eyes such as conjunctivitis and keratitis, especially for gram-negative bacterial infections resistant to gentamicin, such as severe Pseudomonas aeruginosa infections.

Specification